{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:13:55Z","timestamp":1778922835127,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health in Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.puhip.2025.100592","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:21:53Z","timestamp":1739474513000},"page":"100592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trends in public interest and vaccination coverage for Herpes Zoster"],"prefix":"10.1016","volume":"9","author":[{"given":"Santina","family":"Corona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Ianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-2393","authenticated-orcid":false,"given":"Mario","family":"Muselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhip.2025.100592_bib1","first-page":"17","article-title":"Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans Am Clin Climatol Assoc [Internet]"},{"issue":"10","key":"10.1016\/j.puhip.2025.100592_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology [Internet]"},{"issue":"6","key":"10.1016\/j.puhip.2025.100592_bib3","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open [Internet]"},{"issue":"13","key":"10.1016\/j.puhip.2025.100592_bib4","article-title":"A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data","volume":"145","author":"Bollaerts","year":"2017","journal-title":"Epidemiol Infect [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib5","article-title":"Quantification of risk factors for herpes zoster: population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"BMJ [Internet]"},{"issue":"12","key":"10.1016\/j.puhip.2025.100592_bib6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc [Internet]"},{"issue":"11","key":"10.1016\/j.puhip.2025.100592_bib7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc [Internet]"},{"issue":"23\u201324","key":"10.1016\/j.puhip.2025.100592_bib8","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine [Internet]"},{"issue":"6","key":"10.1016\/j.puhip.2025.100592_bib9","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jmv.27538","article-title":"The global disease burden of varicella-zoster virus infection from 1990 to 2019","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib10","author":"Pinchinat"},{"issue":"2","key":"10.1016\/j.puhip.2025.100592_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/21645515.2017.1264834","article-title":"Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study","volume":"13","author":"Alicino","year":"2017","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"4","key":"10.1016\/j.puhip.2025.100592_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther Adv Vaccines [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib13","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis [Internet]"},{"issue":"22","key":"10.1016\/j.puhip.2025.100592_bib14","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med [Internet]"},{"issue":"27","key":"10.1016\/j.puhip.2025.100592_bib15","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.vaccine.2019.04.046","article-title":"Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax\u00ae in healthy adults aged 50 years and older","volume":"37","author":"Choi","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"1","key":"10.1016\/j.puhip.2025.100592_bib16","article-title":"Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study","volume":"19","author":"Ohfuji","year":"2019","journal-title":"BMC Infect Dis [Internet]"},{"issue":"12 Suppl 2","key":"10.1016\/j.puhip.2025.100592_bib17","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J. Infect. Dis. Immun."},{"issue":"8","key":"10.1016\/j.puhip.2025.100592_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/cid\/ciab629","article-title":"The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70","volume":"74","author":"Boutry","year":"2022","journal-title":"Clin Infect Dis [Internet]"},{"issue":"22","key":"10.1016\/j.puhip.2025.100592_bib19","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib21","series-title":"Update on Vaccination against Shingles","year":"2021"},{"key":"10.1016\/j.puhip.2025.100592_bib22","doi-asserted-by":"crossref","unstructured":"P.J. Lu, M.C. Hung, A. Srivastav, W.W. Williams, K.L. Dooling, Shingles vaccination of adults 50\u201359 and \u226560 years, U.S.: prior to recommendations for use of recombinant zoster vaccine, Am J Prev Med 59 (1) (2020 Jul) 21-31. doi: 10.1016\/j.amepre.2020.01.017. Epub 2020 May 7.","DOI":"10.1016\/j.amepre.2020.01.017"},{"key":"10.1016\/j.puhip.2025.100592_bib24","article-title":"Coronavirus (Covid-19) pandemic: how may communication strategies influence our behaviours?","volume":"53","author":"Muselli","year":"2021","journal-title":"Int J Disaster Risk Reduct [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijid.2021.08.018","article-title":"Impact of the world antimicrobial awareness week on public interest between 2015 and 2020: a Google trends analysis","volume":"111","author":"Keitoku","year":"2021","journal-title":"Int J Infect Dis [Internet]"},{"issue":"2","key":"10.1016\/j.puhip.2025.100592_bib26","first-page":"1","article-title":"Retrospective analysis of the accuracy of predicting the alert level of COVID-19 in 202 countries using Google Trends and machine learning","volume":"10","author":"Peng","year":"2020","journal-title":"J Glob Health [Internet]"},{"issue":"1","key":"10.1016\/j.puhip.2025.100592_bib27","article-title":"Using Google Trends to assess the impact of global public health days on online health information seeking behaviour in Central and South America","volume":"10","author":"Havelka","year":"2020","journal-title":"J Glob Health [Internet]"},{"issue":"4","key":"10.1016\/j.puhip.2025.100592_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.23749\/mdl.v109i4.7245","article-title":"Trend analysis and factors associated with biological injuries among health care workers in Southern Italy","volume":"109","author":"Cofini","year":"2018","journal-title":"La Medicina del Lavoro | Work, Environment and Health [Internet]"},{"issue":"1","key":"10.1016\/j.puhip.2025.100592_bib30","article-title":"Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: an updated critical review","volume":"19","author":"Giannelos","year":"2023","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"4","key":"10.1016\/j.puhip.2025.100592_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40520-019-01374-5","article-title":"Vaccination for quality of life: herpes-zoster vaccines","volume":"33","author":"Lang","year":"2021","journal-title":"Aging Clin Exp Res [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-19798-x","article-title":"Impact of the cervical cancer awareness months on public interest in Japan: a Google Trends analysis, 2012\u20132021","volume":"12","author":"Hagiya","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.puhip.2025.100592_bib33","article-title":"Exploring public awareness of overwork prevention with big data from Google trends: retrospective analysis","volume":"22","author":"Lin","year":"2020","journal-title":"J Med Internet Res [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.euros.2022.01.002","article-title":"Online public interest in urological cancers during the COVID-19 pandemic: what can \u201cdr. Google\u201d teach us?","volume":"37","author":"Khene","year":"2022","journal-title":"Eur Urol Open Sci [Internet]"},{"issue":"9","key":"10.1016\/j.puhip.2025.100592_bib35","article-title":"Trends and patterns in the public awareness of palliative care, euthanasia, and end-of-life decisions in 3 central European countries using big data analysis from Google: retrospective analysis","volume":"23","author":"Huemer","year":"2021","journal-title":"J Med Internet Res [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib36","author":"ESMA"},{"key":"10.1016\/j.puhip.2025.100592_bib37","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2015.04.039","article-title":"Addressing vaccine hesitancy: the potential value of commercial and social marketing principles and practices","volume":"33","author":"Nowak","year":"2015","journal-title":"Vaccine [Internet]"},{"issue":"33","key":"10.1016\/j.puhip.2025.100592_bib38","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/j.vaccine.2014.05.044","article-title":"Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys","volume":"32","author":"Cates","year":"2014","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.puhip.2025.100592_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijmedinf.2017.04.018","article-title":"Experiences, practices and barriers to accessing health information: a qualitative study","volume":"103","author":"Scantlebury","year":"2017","journal-title":"Int J Med Inform [Internet]"},{"issue":"2","key":"10.1016\/j.puhip.2025.100592_bib40","first-page":"90","article-title":"Prevalence and factors associated with problematic internet use: an Italian survey among L'Aquila students","volume":"52","author":"Bianchini","year":"2017","journal-title":"Riv Psichiatr [Internet]"},{"issue":"1","key":"10.1016\/j.puhip.2025.100592_bib41","article-title":"Surfing the internet for health information: an Italian survey on use and population choices","volume":"11","author":"Siliquini","year":"2011","journal-title":"BMC Med Inform Decis Mak [Internet]"}],"container-title":["Public Health in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666535225000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666535225000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:47:13Z","timestamp":1778921233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666535225000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"alternative-id":["S2666535225000114"],"URL":"https:\/\/doi.org\/10.1016\/j.puhip.2025.100592","relation":{},"ISSN":["2666-5352"],"issn-type":[{"value":"2666-5352","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in public interest and vaccination coverage for Herpes Zoster","name":"articletitle","label":"Article Title"},{"value":"Public Health in Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhip.2025.100592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}],"article-number":"100592"}}